Welcome to the April BNF eNewsletter.
• Five new drug monographs have been added to the BNF in the last month: mexiletine, cidofovir, insulin glargine with lixisenatide, stiripentol and letermovir. One new drug monograph has been added to the BNFC in the last month: tigecycline.
• We have also included a dose change for rivaroxaban.
• We have included MHRA advice on carbimazole, olaratumab and SGLT2 inhibitors.
Significant updates | Drug safety update | News | How to purchase BNF | Feedback